Back to Agenda
Session 1: FDA Advertising and Promotion Regulatory Updates: Key Developments and Considerations
Session Chair(s)
Twyla Mosey, PharmD
Acting Office Director, OPDP, CDER , FDA, United States
Hear directly from FDA representatives on recent developments, regulatory priorities, and emerging considerations in prescription drug advertising and promotion Gain insights into the evolving regulatory landscape and key areas of interest for industry stakeholders.
Have an account?